Director · Stoke Therapeutics, Inc. · Stoke Therapeutics, Inc. — Director Stock Option (Right to Buy)
Side
A
Value
—
Shares
39.7K
Price
—
Executed
Sep 23, 2026
Disclosed
Sep 25, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 23 executedSep 25, 2026 disclosed
STOK · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Stoke Therapeutics, Inc. — Director Stock Option (Right to Buy)
Ticker
STOK
Shares
39.7K
Price per share
$0
Execution date (reported)
Sep 23, 2026
Owned after transaction
39.7K shares
Days from execution to publication
2
What this establishes
Cumbo Alexander filed this Form 4 reporting a grant or award of STOK on Sep 23, 2026. It became public on Sep 25, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Cumbo Alexandercik:0001685994
Issuer
Stoke Therapeutics, Inc.cik:0001623526
Revision history · 0
No field has changed since this record was first ingested.
